Aqualung Therapeutics (ALT) is developing multi-pronged strategies to address the development of severe lung inflammation which is essential to the severity and outcomes of acute and chronic lung disorders such as acute lung injury, ventilator-induced lung injury (VILI), idiopathic pulmonary fibrosis, and pulmonary hypertension. Effective FDA-approved drugs are either currently unavailable or extraordinarily modest in their ability to modify disease progression. No drug is currently available that is preventive or curative. Aqualung’s strategies, which include deployment of a human monoclonal antibody which targets a novel inflammatory mediator (nicotinamide phosphoribosyltransferase or NAMPT) will address the unmet need for novel, effective therapies for VILI, IPF, and pulmonary hypertension.
Company Details
- Founded
- -
- Address
- 1790 E River Rd, Suite 205,united States
- Phone
- 312-618-7337
- in****@****ics.com
- Industry
- Biotechnology
- Website
- aqualungtherapeutics.com
- Keywords
- Acute Respiratory Distress Syndrome (ARDS), Radiation Induced Lung Injury, Prostate Cancer, ventilator induced lung injury, inflammatory disorders, NAMPT (nicotinamide phosphoribosyltransferase), trauma-induced inflammatory lung injury, humanized mAb, eNamptorTM, Antibody-based therapies.
- HQ
- Tucson, Arizona
Aqualung Therapeutics Corporation Questions
Aqualung Therapeutics Corporation's helpline number is 312-618-7337
Aqualung Therapeutics Corporation's website is aqualungtherapeutics.com
Aqualung Therapeutics Corporation's LinkedIn profile is https://www.linkedin.com/company/aqualung-therapeutics-corp.
Aqualung Therapeutics Corporation's industry is
Biotechnology
Aqualung Therapeutics Corporation's top competitors are
Inanobio,
Imetabolic Biopharma Corporation,
Avery Therapeutics, Inc.,
Pepex Biomedical, Inc.,
Axolotl Biologix,
Microvascular Therapeutics,
Raesedo Inc,
Pathogendx,
Applied Biologics Llc,
Aspiro Therapeutics.
Aqualung Therapeutics Corporation's support email address is info@aqualungtherapeutics.com
Aqualung Therapeutics Corporation's categories are Biotechnology
Aqualung Therapeutics Corporation's founding year is 2010
